MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202421007347 A) filed by Lord's Mark Industries Limited, Maharashtra, on Feb. 2, 2024, for 'a diagnostic test kit for serum glutamic pyruvic transaminase (sgpt) / alanine aminotransferase (alt).'
Inventor(s) include Lord's Mark Industries Limited.
The application for the patent was published on Aug. 8, under issue no. 32/2025.
According to the abstract released by the Intellectual Property India: "A diagnostic test kit for Serum Glutamic Pyruvic Transaminase (SGPT) / Alanine Aminotransferase (ALT) A diagnostic test kit for Serum Glutamic Pyruvic Transaminase (SGPT) / Alanine Aminotransferase (ALT) consist of a kit of Tris, Laspartate and Lactate Dehydrogenase (LDH) to form reagent I cell and and Nicotinamide Adenine Dinucleotide (NADH) to form reagent II cell operates through a process includes transferring the reagent cell I and II at room temperature in to the blood serum/ plasma sample test tubes; incubating the reaction mixture; determining the absorbance of said test sample on photometer; and finally calculating the absorbance using factor to determine Serum Glutamic Pyruvic Transaminase (SGPT) / Alanine Aminotransferase (ALT) in vitro from the test serum / plasma sample effectively."
Disclaimer: Curated by HT Syndication.
